Skip to main content

Event Category


Article available in the folowing languages:

Innovabone Conference - Biomaterials for bone regeneration

Two days of sharing and learning the latest results obtained by the EU-funded project InnovaBone - biomaterials for bone regeneration. The conference will gather scientists, representatives from patients associations, health professionals, policy makers, industrial players and citizens to explore how to place InnovaBone into future orthopedic practice and maximize its business opportunities. Registration and more info

14 October 2015 - 15 October 2015

14 October 2015
INNOVABONE impact on healthcare & SMEs' competitiveness
09:00-13:00 Building bridges from bench to bedside
14:30-17:30 Growth of SMEs through EU projects
In the morning, you will have the opportunity to engage in an open dialogue with different stakeholders on how InnovaBone will impact future patients care. Success stories of how to boost SME competitiveness through EU research projects will follow in the afternoon through the presentation of 4 companies involved in InnovaBone. This is an EU “Open Days 2015” side event.

15 October 2015
Sharing the achievements of INNOVABONE biomimetic strategy
09:00-17:00 Digging deeper into InnovaBone science
The second day will be fully dedicated to sharing InnovaBone results in biomimetic strategies for bone regeneration.
InnovaBone scientists and distinguished external experts will discuss scientific achievements and highlight future challenges in regenerative medicine.

With the aim of developing biomaterials for bone repair, the project started 4 years ago under the coordination of Oskar Hoffmann from the Department of Pharmacology and Toxicology at the University of Vienna. There are 14 partners spread across Europe (Austria, Italy, United Kingdom, Germany, Netherlands, Belgium, Switzerland and Spain) that have integrated several fields of expertise in bone biology, orthopedic medicine, materials science, polymer chemistry, synthetic biology, nanoparticle engineering, non-invasive imaging technology, experimental allergy, immunology, toxicology and cross-cutting issues to fulfil the aim of the project.